APH vs CVS · P/E 40, rev $23.09B vs P/E 16, rev $402.07B
Amphenol Corporation (APH) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
APH currently screens at market cap $170.77B and trailing P/E 39.9. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the APH and CVS stock pages for the full models.
Not investment advice.